Ada Henrike Braun
Affiliation: Vanderbilt University
- Lysophosphatidic acid, a disintegrin and metalloprotease-17 and heparin-binding epidermal growth factor-like growth factor in ovarian cancer: the first word, not the lastAda H Braun
Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee 37232, USA
Clin Cancer Res 11:4639-43. 2005
- The epidermal growth factor receptor tyrosine kinase inhibitor gefitinib sensitizes colon cancer cells to irinotecanAda Henrike Braun
Department of Internal Medicine Cancer Research, West German Cancer Center, Essen, Germany
Anticancer Drugs 16:1099-108. 2005..This study delineates mechanisms that may contribute to the synergism observed between irinotecan and EGFR inhibitors...